Literature DB >> 33740017

B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy.

Senka Sendic1, Ladan Mansouri2, Sigrid Lundberg1, Anna Nopp2, Stefan H Jacobson1, Joachim Lundahl2.   

Abstract

BACKGROUND: IgA nephropathy (IgAN) advances from multiple pathogenic "hits" resulting in poorly O-galactosylated IgA1 glycoforms (Gd-IgA1), production of antibodies and glomerular deposition of immune complexes. A sequence of immune responses arising from plasma cells, T cells and antigen presenting cells (APCs), causes glomerular injury. This study was designed to phenotype subsets of B cells, monocytes and T cells in the peripheral circulation and their association with inflammatory cytokines and kidney function in patients with IgAN, healthy controls (HC) and disease controls with autosomal dominant polycystic kidney disease (ADPKD).
METHODS: Patients with IgAN (n = 13), median estimated glomerular filtration rate (eGFR) of 57 ml/min/1.73m2 (IQR 42-84), patients with ADPKD (n = 13) matched for kidney function, gender and age and gender and age-matched HC (n = 13) were recruited. CD3+ and CD3- peripheral blood mononuclear cells were isolated and profiled based on their specific surface markers for different subsets of monocytes, B and T cells and analyzed by flow cytometry. Cytokines were analyzed by ELISA.
RESULTS: We observed a significant decrease in the proportion of pre-switched B cells and plasmablasts, but an increase in long-lived plasma cells in the peripheral circulation of IgAN patients compared to HC. The proportion of non-classical monocytes was significantly higher in IgAN patients compared to both HC and ADPKD. We also report an association between sCD40L levels and the proportion of pre-switched B cells, as well as sCD40L and MCP-1 levels and albuminuria in IgAN patients.
CONCLUSIONS: We applied an easy-access method to analyze subsets of immune cells as well as relevant inflammatory mediators in IgAN patients. Our data demonstrate an altered B cell profile that indicates a pathophysiological role of the B cell lineage and an increased proportion of non-classical monocytes that suggests their role in the disease process.

Entities:  

Year:  2021        PMID: 33740017      PMCID: PMC7978284          DOI: 10.1371/journal.pone.0248056

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  39 in total

Review 1.  Plasma cells as an innovative target in autoimmune disease with renal manifestations.

Authors:  Falk Hiepe; Andreas Radbruch
Journal:  Nat Rev Nephrol       Date:  2016-02-29       Impact factor: 28.314

Review 2.  The pathophysiology of IgA nephropathy.

Authors:  Hitoshi Suzuki; Krzysztof Kiryluk; Jan Novak; Zina Moldoveanu; Andrew B Herr; Matthew B Renfrow; Robert J Wyatt; Francesco Scolari; Jiri Mestecky; Ali G Gharavi; Bruce A Julian
Journal:  J Am Soc Nephrol       Date:  2011-09-23       Impact factor: 10.121

Review 3.  Standardizing immunophenotyping for the Human Immunology Project.

Authors:  Holden T Maecker; J Philip McCoy; Robert Nussenblatt
Journal:  Nat Rev Immunol       Date:  2012-02-17       Impact factor: 53.106

4.  Detection of urinary macrophages expressing the CD16 (Fc gamma RIII) molecule: a novel marker of acute inflammatory glomerular injury.

Authors:  O Hotta; N Yusa; M Ooyama; K Unno; T Furuta; Y Taguma
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

Review 5.  Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome.

Authors:  Giuseppe D'Amico
Journal:  Semin Nephrol       Date:  2004-05       Impact factor: 5.299

6.  Increased Non-switched Memory B Cells are Associated with Plasmablasts, Serum IL-6 Levels and Renal Functional Impairments in IgAN Patients.

Authors:  Rui Si; Pingwei Zhao; Zhenxiang Yu; Zhihui Qu; Weixia Sun; Tao Li; Yanfang Jiang
Journal:  Immunol Invest       Date:  2019-10-31       Impact factor: 3.657

Review 7.  An update on the pathogenesis and treatment of IgA nephropathy.

Authors:  Joanna K Boyd; Chee K Cheung; Karen Molyneux; John Feehally; Jonathan Barratt
Journal:  Kidney Int       Date:  2012-02-08       Impact factor: 10.612

8.  Vascular Endothelial Growth Factor C for Polycystic Kidney Diseases.

Authors:  Jennifer L Huang; Adrian S Woolf; Maria Kolatsi-Joannou; Peter Baluk; Richard N Sandford; Dorien J M Peters; Donald M McDonald; Karen L Price; Paul J D Winyard; David A Long
Journal:  J Am Soc Nephrol       Date:  2015-06-02       Impact factor: 10.121

9.  Phenotypic characterization of human intermediate monocytes.

Authors:  Daniëlle Hijdra; Adriane D M Vorselaars; Jan C Grutters; Anke M E Claessen; Ger T Rijkers
Journal:  Front Immunol       Date:  2013-10-22       Impact factor: 7.561

10.  CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus.

Authors:  Huaqun Zhu; Fanlei Hu; Xiaolin Sun; Xiaoying Zhang; Lei Zhu; Xu Liu; Xue Li; Liling Xu; Lianjie Shi; Yuzhou Gan; Yin Su
Journal:  Front Immunol       Date:  2016-11-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.